©The Author(s) 2025.
World J Transplant. Dec 18, 2025; 15(4): 102995
Published online Dec 18, 2025. doi: 10.5500/wjt.v15.i4.102995
Published online Dec 18, 2025. doi: 10.5500/wjt.v15.i4.102995
Table 2 Scoring systems used in aortic valve replacement
| System | Description | Strengths | Limitations |
| Child-Turcotte Pugh | Developed for surgical risk stratification; assesses risk using five parameters: Ascites, encephalopathy, bilirubin, albumin, and INR | Incorporates clinical factors like ascites and encephalopathy | Subjectivity in grading ascites and encephalopathy |
| Model for End-Stage Liver Disease | Developed for short-term mortality prediction and organ allocation; calculates score from bilirubin, creatinine, sodium, INR; recently incorporated sex + albumin (3.0) | Objective lab values reduce subjectivity; new version incorporates gender | Does not directly assess cardiac risk; limited predictive accuracy for perioperative outcomes; historic gender vias; several iterations |
| Model for End-Stage Liver Disease- excluding INR | Modified MELD score that excludes INR | More accurate in predicting 6-month mortality post-TAVR; May not confound bleeding risk with INR | Not routinely used in adult patients |
| European System for Cardiac Operative Risk Evaluation | Assesses risk of mortality after cardiac surgery based on comorbidities | Widely used for preoperative cardiac risk assessment; considers type of cardiac surgery performed | Does not incorporate liver function; underpredicts mortality in cirrhotic patients |
| Society of Thoracic Surgeons Risk Score | Assesses risk of mortality after cardiac surgery based on anthropometric profile, comorbidities, medications, labs, and socioeconomic factors | Broader assessment of clinical status; commonly used for valve replacement; includes history of liver disease | May under-estimate risk in cirrhosis; poorly associated with outcomes in patients with cirrhosis in present studies |
| Veterans Outcomes and Costs Associated with Liver Disease Model | Developed to predict post-operative mortality in patients with cirrhosis, for any surgical procedures | Demonstrated superior discrimination than other surgical risk calculators | Lack of prospective data; data predominantly in men |
- Citation: Osorio B, Fox SW, Cooper KM, Chandragiri S, Mohani AF, Devuni D. Aortic stenosis in cirrhosis: Pathophysiology and management in the context of liver transplantation. World J Transplant 2025; 15(4): 102995
- URL: https://www.wjgnet.com/2220-3230/full/v15/i4/102995.htm
- DOI: https://dx.doi.org/10.5500/wjt.v15.i4.102995